ArticleBMC public health2025
Predictors of hearing screening among residents of Saudi Arabia at primary healthcare settings in Riyadh: useful insights from a cross-sectional survey.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- The prevalence and predictors of previous prostate cancer screening among men attending primary healthcare centers in Riyadh, Saudi Arabia.Annals of medicine · 2026Article
- Article
- Factors associated with healthcare seeking behavior from private clinics among patients in Riyadh, Saudi Arabia.BMC health services research · 2026Article
- Prevalence of Hearing Impairment in Saudi Arabia: Pathways to Early Diagnosis, Intervention, and National Policy.Healthcare (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDespite the significant prevalence of hearing impairment and the devastating impact on the quality of life, screening patterns regarding hearing loss in adults are significantly reduced. It is necessary to identify the proportion of residents of Saudi Arabia which undergo for hearing screening and identify predictors of hearing loss. Therefore, we conducted this study to identify predictors of the hearing screening among residents of Saudi Arabia.
methodsA cross-sectional study was undertaken, and an electronic questionnaire was administered to 14,239 patients who visited primary health care centers. Primary health care centers were selected using a random sampling technique. Data was collected on hearing screening and other sociodemographic and behavioural factors along with other co-morbidities. We performed multiple logistic regressions to identify predictors that were significantly associated with hearing screening. We performed analysis using SPSS version 26.0 for Windows and reported adjusted odds ratios (AORs) with 95% CIs.
resultsThe sample consisted of 43.4% males and 65.3% married participants. Only 5.9% of the study participants reported going for hearing screening. Age (AOR: 1.01; 95% CI: 1.01, 1.02); higher education level (AOR: 2.46; 95% CI: 1.55, 3.92), full time employment (AOR: 1.36; 95% CI: 1.05, 1.75), part time employment (AOR: 1.54; 95% CI: 1.22, 1.94), good health status (AOR: 1.52; 95% CI: 1.17, 1.96), and Diabetes Mellitus (AOR: 1.37; 95% CI: 1.08, 1.72) were found to be strong predictors of hearing screening among residents of Saudi Arabia in Riyadh.
conclusionWe found a very low prevalence of hearing screening among residents of Saudi Arabia. Older age, educated, employed, people with good status health, and diabetic individuals were more likely to go for hearing screening. Health literacy sessions need to be carried out to raise awareness among residents of Saudi Arabia and more robust epidemiological studies need to be carried out to explore the reasons of low hearing screening in this population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.